Seeking Alpha

More good news for Synovis (SYNO) shareholders, as FQ4 earnings rose a better-than-expected 83%,...

More good news for Synovis (SYNO) shareholders, as FQ4 earnings rose a better-than-expected 83%, continuing the medical device company's streak of double-digit sales growth. Sales of its Peri-Strips for gastric bypass surgery, the biggest contributor to its top line, climbed 28%. Yesterday, SYNO agreed to be acquired by Baxter (BAX) for $28/share.
Comments (1)
  • User 79194
    , contributor
    Comments (2) | Send Message
     
    The management was remiss in not opening up the bidding for all to see. They could have gotten $35.00 plus from other companies. Shareholders were screwed.
    15 Dec 2011, 09:10 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector